Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
11m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
43m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
44m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
44m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
44m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Anbio Biotechnology Class A Ordinary Shares logo

Anbio Biotechnology Class A Ordinary Shares

About

Anbio Biotechnology Class A Ordinary Shares (NASDAQ:NNNN) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 17 2026
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Oct 9 2025
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025
Aug 8 2025
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
May 15 2025
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
Feb 20 2025
Anbio Biotechnology Announces Closing of Initial Public Offering

Financials

Revenue
$6.92 M
Market Cap
$1.15 B
P/E Ratio
435.75
EPS
0.06

Community Chat

Ask AI

6ix6ixAIEvents